Age: 24
Free Agency: 2024 (UFA)
Accrued Seasons: 3
- Height: 6'4"
- Weight: 250
- College: LSU
- Entry: 2020 Draft, Round 1, #20 overall (Jaguars)
- 2023 Salary Cap Charge: $4,246,012 (1.88% of cap)
- 2023 Cash Payout: $2,429,719 (0.93% of spending)
- 2023 Cash to Cap Ratio: 0.57
- Contract Value: $13,344,610 ($3,336,153 APY)
- Fully Guaranteed Money: $13,344,610
- Contract Ranking: 53/248 at EDGE
Current Contract
(Drafted, signed 2020)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 21 | $610,000 | $1,816,293 | $610,000 | $2,426,293 | 1.2% | |||||
| 2021 | 22 | $1,216,573 | $1,816,293 | $1,216,573 | $3,032,866 | 1.5% | |||||
| 2022 | 23 | $1,823,146 | $1,816,293 | $1,823,146 | $3,639,439 | 1.6% | |||||
| 2023 | 24 | $2,429,719 | $1,816,293 | $2,429,719 | $4,246,012 | 1.9% | |||||
| Total | $6,079,438 | $7,265,172 | $6,079,438 | $13,344,610 | |||||||
Contract Notes
K'Lavon Chaisson signed his rookie contract with Jacksonville Jaguars on July 19, 2020. The contract is a 4 year deal with a 5th year team option, worth $13,344,610 fully guaranteed including a $7,265,172 signing bonus. The guaranteed salaries include "no offset" language.
Cash Flows
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Cash Due | $7,875,172 | $1,216,573 | $1,823,146 | $2,429,719 |
| Running Cash | $7,875,172 | $9,091,745 | $10,914,891 | $13,344,610 |
Career Earnings: $10,914,891
Career APY: $3,638,297
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguars | Drafted | Active | 2020 | 4 | $13,344,610 | $3,336,153 | $13,344,610 | $10,914,891 | 81.8% | $3,638,297 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Jaguars | 3 | $10,914,891 | $3,638,297 | $9,098,598 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|
| 2020 | Jaguars | $610,000 | $1,816,293 | $610,000 | $2,426,293 | 1.2% | $7,875,172 | ||
| 2021 | Jaguars | $1,216,573 | $1,816,293 | $1,216,573 | $3,032,866 | 1.5% | $1,216,573 | ||
| 2022 | Jaguars | $1,823,146 | $1,816,293 | $1,823,146 | $3,639,439 | 1.6% | $1,823,146 | ||
| 2023 | Jaguars | $2,429,719 | $1,816,293 | $2,429,719 | $4,246,012 | 1.9% | $2,429,719 | ||
| Total | $6,079,438 | $7,265,172 | $6,079,438 | $13,344,610 | $13,344,610 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | |||
| 2020 | 16 | 0 | 0 | 50.7% | 5.5% | 12 | 7 | 1 | 8 | 3 | 9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 15 | 0 | 0 | 34.7% | 25.5% | 20 | 11 | 1 | 2 | 3 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 9 | 1 | 0 | 9.4% | 25.6% | 6 | 3 | 1 | 9 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $752,000 | $3,336,153 |
| Injury Adjusted | $864,382 | $3,127,643 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.